Description
SHP389 is an allosteric SHP2 inhibitor, with an IC 50 of 36 nM for both SHP2 and p-ERKIn VivoSHP389 modulates MAPK signaling in vivo. MCE has not independently confirmed the accuracy of these methods. They are for reference only.Form:SolidIC50& Target:IC50: 36 nM (SHP2 and p-ERK)